Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Genentech files for U.S. approval of Lucentis for diabetic retinopathy

Aug. 11, 2014

No Comments

Eylea approved in E.U. for DME

Aug. 11, 2014

No Comments

Oraya Therapeutics awarded grant for gold nanoparticles

Aug. 8, 2014

No Comments

Targazyme awarded grant to study treatment of retinopathy using autologous stem cells

Aug. 5, 2014

No Comments

FDA approves Eylea for diabetic macular edema

July 30, 2014

No Comments

Simbrinza approved in the E.U. to treat glaucoma

July 29, 2014

No Comments

CHMP recommends extension of Ozurdex indication in diabetic macular edema

July 28, 2014

No Comments

Kalvista Pharmaceuticals discloses new plasma kallikrein inhibitors

July 28, 2014

No Comments

Bayer reports 2-year results from VIVID-DME study of aflibercept

July 21, 2014

No Comments

Aerie initiates phase III registrational program for Rhopressa in glaucoma

July 15, 2014

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

Genentech files for U.S. approval of Lucentis for diabetic retinopathy

Eylea approved in E.U. for DME

Oraya Therapeutics awarded grant for gold nanoparticles

Targazyme awarded grant to study treatment of retinopathy using autologous stem cells

FDA approves Eylea for diabetic macular edema

Simbrinza approved in the E.U. to treat glaucoma

CHMP recommends extension of Ozurdex indication in diabetic macular edema

Kalvista Pharmaceuticals discloses new plasma kallikrein inhibitors

Bayer reports 2-year results from VIVID-DME study of aflibercept

Aerie initiates phase III registrational program for Rhopressa in glaucoma

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice

Ocular RSS

Ocular
RSS